Sharon K Fey, PA C Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 700 4th Street, Ste 410, Sioux City, IA 51101 Phone: 712-255-7746 Fax: 712-255-0829 |
Liem Som Oei, MD Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 700 4th Street, Ste 410, Sioux City, IA 51101 Phone: 712-255-7746 Fax: 712-255-0829 |
Caridad C Tan, MD Internal Medicine - Nephrology Medicare: Medicare Enrolled Practice Location: 2730 Pierce St Ste 402a, Sioux City, IA 51104 Phone: 712-252-8191 Fax: 712-252-8192 |
Min-hwa Hwa Chow, M.D. Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 600 4th Street, Suite 103, Sioux City, IA 51101 Phone: 712-255-7746 Fax: 712-255-0829 |
News Archive
Results of a 275-patient, multi-national phase III clinical trial known as ALTA-1L published today in the New England Journal of Medicine and presented concurrently in the press program at the International Association for the Study of Lung Cancer (IASLC) World Conference on Lung Cancer 2018 argue for brigatinib as a first-line treatment option for advanced ALK-positive non-small cell lung cancer.
A new technology is showing promise as the basis for a much-needed home test to diagnose influenza quickly, before the window for taking antiviral drugs slams shut and sick people spread the virus to others, scientists reported here today. In a presentation at the 246th National Meeting & Exposition of the American Chemical Society (ACS), they described how it also could determine the specific strain of flu virus and help select the most effective drug for treatment.
The National Cancer Institute (NCI) estimates that as many as one in 51 men and women will be diagnosed with melanoma-the deadliest form of skin cancer-at some point during their lifetimes. A research team led by Ze'ev Ronai, Ph.D. at Sanford-Burnham Medical Research Institute (Sanford-Burnham) is working to unravel the molecular mechanisms underlying the development and progression of this disease in hopes of improving prevention and treatment strategies
Medical Properties Trust, Inc. announced today that it closed the sale of its previously announced underwritten public offering of shares of common stock, which included 26 million shares of common stock issued on April 20, 2010 and 3.9 million shares of common stock issued on April 22, 2010 pursuant to the exercise in full of the underwriters' over-allotment option.
› Verified 1 days ago